Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

In 2008, the U.S. House of Representatives designated July as Bebe Moore Campbell National Minority Mental Health Awareness ...

Let’s talk about sex.An online survey of more than 1,700 breast cancer survivors showed that most respondents experienced ...

The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...

An oral neutrophil modulator appeared safe and demonstrated signals of efficacy in patients with moderate to severe ...

Nearly 5 months after several companies voluntarily agreed to recall select acne products due to elevated benzene levels, uncertainty remains regarding any clinical risk with the formulations that ...

Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.

The FDA appointed George F. Tidmarsh, MD, PhD, the director of the Center for Drug Evaluation and Research, the agency ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

Individuals with word-finding difficulties during prodromal migraine showed reduced objective performance in metrics of ...

Rain Eye Drops launched the RainDrop Dispenser Aid, a device aimed at making single-dose eye drop vials easier to use, ...

The iris, for all its intricacies, gets the attention of us eye doctors only when it causes problems for our patients.As a ...